Pharma boss: EU will have to focus on long-term medical research ecosystem

After the coronavirus crisis is over, Europe will need policies that can create a research ecosystem in the long run as well as ensure access to medicines to the patients who need them in a way that is sustainable for health systems today and tomorrow, a leading representative of European pharmaceuticals told EURACTIV in an interview.

Nathalie Moll: "EFPIA members are working around the clock to find vaccines, diagnostics and treatments to use in the fight against coronavirus." [Sarantis Michalopoulos]

Donec et orci aliquet nisl suscipit molestie sed sit amet tortor. Duis vel urna ac mi sollicitudin lacinia mollis sit amet lorem. Sed finibus erat nec libero scelerisque fringilla. Morbi at orci sed urna vulputate vulputate. Nulla facilisi. Donec et orci aliquet nisl suscipit molestie sed sit amet tortor.

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro
For corporations

More from this section

Browse all articles

More from this author

Browse all articles

Subscribe to our newsletters

Subscribe